Harnessing ‘brainpower’ to improve function and reduce pain
Musculoskeletal injuries and pain are a significant cause of disability. This is a worldwide problem. Read More...
Clinical Articles
Managing addictions differently
Stress causes release responses of adrenaline, noradrenaline, endogenous opioids, endogenous cannabinoids and endogenous benzodiazepines. Recurrent stress is known to cause damage at the various related receptors causing anxiety, depression, hypertension, disturbance of the HPA axis, and addiction. Read More...
Exploring innovative approaches in the management of obesity
The management of obesity necessitates a comprehensive approach involving lifestyle interventions, potential pharmacotherapy, and/or bariatric surgery for certain individuals. Read More...
Treatment resistant depression
A new WA-based study aims to improve outcomes in treatment resistant depression. Major Depressive Disorder (MDD) is one of the leading causes of illness and disease burden in Australia. In the 2021 Australian National Health Survey, 8% of people surveyed had experienced a mood (affective) disorder in the previous 12 months. Read More...
Rethinking diabetes in children
A 13-year-old boy presents to your rural GP practice with a sore throat, abdominal pain and general malaise. You note he is tachypnoeic. His mother mentions some weight loss over the past two weeks though she had not been concerned about this because his weight was >95th centile and BMI >98th centile. Read More...
ThyroSeq® v3 — a new molecular test for thyroid nodules
Ensuring a definitive result for indeterminate cases and reducing the need for surgery. Read More...
Teamwork needed to halt infectious syphilis outbreak
Western Australia is experiencing an ongoing outbreak of infectious syphilis. We need to work together across all sectors of primary care and tertiary health services to halt this outbreak and ensure better health outcomes for everyone. Read More...
UTIs can get complicated
Infectious disease specialist and clinical microbiologist Dr Jonathan Chambers was one of the doctors who was consulted by WA Health before the decision was made to go ahead with the pharmacy prescribing trial. This is his take. Read More...